Physician

Andrew L Dejong, M.D.

According to 2025 Medicare claims, Andrew Dejong, M.D. (NPI: 1750328092) practices otolaryngology in the College Station-Bryan, TX market, with the plurality of this provider's patient population coming from Brazos, TX. This provider's primary affiliated billing organization is TEXAS ENT & ALLERGY ASSOCIATES, LLP (NPI: 1962517672; TIN: 202972550) and primary practice location at 77845-4063. Dejong is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Baylor Scott & White Quality Alliance (ACO ID: A2542), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dejong's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,037 traditional Medicare patients, billed 6,127 HCPCS/CPT codes, and received $282,678 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 609 prescription claims across 258 beneficiaries totaling $17,752 in drug costs, led by Epinephrine (Epinephrine). DME data shows 175 claims. Open Payments data shows 3 records totaling $151. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $48,322 to $17,752. For DME billing, reported payments moved sharply higher in recent years, from $4,896 to $8,576.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	971	4,877	$214,831
2016	1,023	4,770	$214,335
2017	1,075	6,190	$246,104
2018	1,044	6,440	$221,505
2019	1,077	6,524	$223,387
2020	934	5,623	$199,062
2021	1,111	6,828	$273,468
2022	1,111	6,414	$277,889
2023	1,071	6,119	$276,072
2024	1,037	6,127	$282,678

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	204	457	$48,322
2016	183	435	$42,281
2017	194	450	$40,070
2018	198	470	$29,719
2019	230	535	$33,174
2020	211	555	$34,426
2021	245	585	$32,130
2022	264	638	$26,176
2023	213	590	$23,971
2024	258	609	$17,752

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$1,003
2016	N/R	68	$1,923
2017	N/R	32	$355
2018	N/R	24	$185
2019	N/R	29	$685
2020	N/R	47	$1,053
2021	N/R	14	$829
2022	N/R	57	$2,020
2023	22	201	$9,212
2024	33	175	$6,530

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	360	360	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	626	1,136	$63
69210	Removal of impacted ear wax	291	377	$32
92557	Comprehensive hearing and speech recognition test	303	345	$25
92567	Test to assess middle ear function	316	372	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Epinephrine	Epinephrine	21	717	$4,203
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	25	269	$2,823
Ipratropium Bromide	Ipratropium Bromide	84	2,044	$2,337
Ofloxacin	Ofloxacin	60	553	$1,885
Montelukast Sodium	Montelukast Sodium	87	4,481	$812

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	43	$1,611
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	21	$1,558
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	22	$1,470
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	N/R	21	$858
A7038	Filter, disposable, used with positive airway pressure device	N	11	34	$408

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$151	Cochlear Americas
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew L. Dejong, M.D.?

Tedicare shows public-source Medicare data for Andrew L. Dejong, M.D. (NPI 1750328092), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew L. Dejong, M.D. have ACO affiliation data?

Andrew L. Dejong, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Andrew L. Dejong, M.D.?

Andrew L. Dejong, M.D. is linked to TEXAS ENT & ALLERGY ASSOCIATES, LLP (billing NPI 1962517672) in the available physician profile data.

Does Andrew L. Dejong, M.D. have Open Payments data?

Andrew L. Dejong, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.